Jacobs Levy Equity Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-811,512
| Closed | -$2.32M | – | 1067 |
|
|
2024
Q3 | $2.32M | Sell |
811,512
-115,494
| -12% | -$330K | 0.01% | 573 |
|
|
2024
Q2 | $2.71M | Buy |
927,006
+96,879
| +12% | +$283K | 0.01% | 554 |
|
|
2024
Q1 | $2.65M | Buy |
830,127
+391,801
| +89% | +$1.25M | 0.01% | 551 |
|
|
2023
Q4 | $1.47M | Buy |
+438,326
| New | +$1.47M | 0.01% | 656 |
|
|
2022
Q3 | – | Sell |
-90,445
| Closed | -$233K | – | 1197 |
|
|
2022
Q2 | $233K | Buy |
90,445
+76,233
| +536% | +$196K | ﹤0.01% | 950 |
|
|
2022
Q1 | $64K | Sell |
14,212
-314,169
| -96% | -$1.41M | ﹤0.01% | 984 |
|
|
2021
Q4 | $2.24M | Sell |
328,381
-16,563
| -5% | -$113K | 0.02% | 598 |
|
|
2021
Q3 | $2.52M | Sell |
344,944
-19,227
| -5% | -$140K | 0.02% | 568 |
|
|
2021
Q2 | $3.65M | Sell |
364,171
-20,645
| -5% | -$207K | 0.02% | 494 |
|
|
2021
Q1 | $3.68M | Buy |
384,816
+359,002
| +1,391% | +$3.43M | 0.03% | 481 |
|
|
2020
Q4 | $283K | Buy |
+25,814
| New | +$283K | ﹤0.01% | 932 |
|